Mapping Spatial and Temporal Changes in Carotid Atherosclerosis from Three-Dimensional Ultrasound Images

Ultrasound in Medicine and Biology

Volumn 34, Issue 1, 2008, Pages 64-72

  Egger, Micaela ^a   Chiu, Bernard ^a,b   Spence, J David ^a   Fenster, Aaron ^a,b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

3D Ultrasound; Atherosclerosis; Carotid plaque; Stenosis; Thickness maps; Vessel wall volume

Indexed keywords

BIOLOGICAL ORGANS; CONFORMAL MAPPING; MEDICAL PROBLEMS; THICKNESS MEASUREMENT; ULTRASONICS;

ATHEROSCLEROSIS; CAROTID PLAQUE; STENOSIS; THICKNESS MAPS; THREE-DIMENSIONAL ULTRASOUND (3DUS); VESSEL WALL VOLUME (VWV);

MEDICAL IMAGING;

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; BLOOD VESSEL WALL; CAROTID ARTERY; CAROTID ARTERY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTIMA; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; THICKNESS; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TUNICA MEDIA; ULTRASOUND; ULTRASOUND TRANSDUCER;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; CAROTID STENOSIS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PYRROLES; TREATMENT OUTCOME;

EID: 37049034055     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2007.07.004     Document Type: Article

References (43)

1. Aikawa M., Rabkin E., Okada Y., Voglic S.J., Clinton S.K., Brinckerhoff C.E., Sukhova G.K., and Libby P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization. Circulation 97 (1998) 2433-2444
2. Ainsworth C.D., Blake C.C., Tamayo A., Beletsky V., Fenster A., and Spence J.D. 3D ultrasound measurement of change in carotid plaque volume: A tool for rapid evaluation of new therapies. Stroke 36 (2005) 1904-1909
3. Armstrong M.L., Warner E.D., and Connor W.E. Regression of coronary atheromatosis in rhesus monkeys. Circ Res 27 (1970) 59-67
4. Ashrafian H., Lim T.K., and Senior R. Carotid ultrasound imaging: An effective technique for detecting early atherosclerosis-vascular screening for cardiovascular disease has come of age. J Am Soc Echocardiogr 20 (2007) 1-3
5. Brown B.G. Regression of atherosclerosis-An ounce of prevention. Western J Medicine 159 (1993) 208-210
6. Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., Dowdy A.A., Marino E.K., Bolson E.L., Alaupovic P., Frolich J., and Albers J.J. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345 (2001) 1583-1592
7. Brown G., Albers J.J., Fisher L.D., Schaefer S.M., Lin J.T., Kaplan C., Zhao X.Q., Bisson B.D., Fitzpatrick V.F., and Dodge H.T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
8. Chiu B., Egger M., Spence J.D., Parraga G., and Fenster A. Quantification of carotid vessel atherosclerosis. Proc SPIE 6143 (2006) 61430B
9. Chiu B., Egger M., Spence J.D., Parraga G., and Fenster A. Quantification of progression and regression of carotid vessel atherosclerosis using 3D ultrasound images. Proc 28th Int Conf IEEE/EMBS (2006), IEEE, Piscataway, NJ 3819-3822
10. Corti R. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy. Pharmacol Ther 110 (2006) 57-70
11. Corti R., Fayad Z.A., Fuster V., Worthley S.G., Helft G., Chesebro J., Mercuri M., and Badimon J.J. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104 (2001) 249-252
12. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Smith D., Weinberger J., Wentzel J., Mizsei G., Mercuri M., and Badimon J.J. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
13. Crawford D.W., Brooks S.H., Selzer R.H., Barndt Jr. R., Beckenbach E.S., and Blankenhorn D.H. Computer densitometry for angiographic assessment of arterial cholesterol content and gross pathology in human atherosclerosis. J Lab Clin Med 89 (1977) 378-392
14. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 103 (2001) 926-933
15. Dansky H.M., and Fisher E.A. High-density lipoprotein and plaque regression: The good cholesterol gets even better. Circulation 100 (1999) 1762-1763
16. Egger M., Spence J.D., Fenster A., and Parraga G. Validation of 3D ultrasound vessel wall volume: An imaging phenotype of carotid atherosclerosis. Ultrasound Med Biol 33 (2007) 905-914
17. Fayad Z.A., and Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 89 (2001) 305-316
18. Fritz K.E., Augustyn J.M., Jarmolych J., Daoud A.S., and Lee K.T. Regression of advanced atherosclerosis in swine: chemical studies. Arch Pathol Lab Med 100 (1976) 380-385
19. Genest J., and Pedersen T.R. Prevention of cardiovascular ischemic events: High-risk and secondary prevention. Circulation 107 (2003) 2059-2065
20. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
21. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
22. Klein L.W. Atherosclerosis regression, vascular remodeling, and plaque stabilization. J Am Coll Cardiol 49 (2007) 271-273
23. Landry A., and Fenster A. Theoretical and experimental quantification of carotid plaque volume measurements made by three-dimensional ultrasound using test phantoms. Med Phys 29 (2002) 2319-2327
24. Landry A., Spence J.D., and Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 35 (2004) 864-869
25. Lima J.A., Desai M.Y., Steen H., Warren W.P., Gautam S., and Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110 (2004) 2336-2341
26. Mercuri M., Bond M.G., Sirtori C.R., Veglia F., Crepaldi G., Feruglio F.S., Descovich G., Ricci G., Rubba P., Mancini M., Gallus G., Bianchi G., D'Alo G., and Ventura A. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 101 (1996) 627-634
27. Newby D.E. Can intensive statin therapy cause regression of coronary atherosclerosis?. Nat Clin Practice Cardiovasc Med 3 (2006) 354-355
28. Nissen S.E., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., Davignon J., Erbel R., Fruchart J.C., Tardif J.C., Schoenhagen P., Crowe T., Cain V., Wolski K., Goormastic M., and Tuzcu E.M. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
29. Nissen S.E., Tsunoda T., Tuzcu E.M., Schoenhagen P., Cooper C.J., Yasin M., Eaton G.M., Lauer M.A., Sheldon W.S., Grines C.L., Halpern S., Crowe T., Blankenship J.C., and Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 290 (2003) 2292-2300
30. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., Grines C.L., and DeMaria A.N. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 291 (2004) 1071-1080
31. Nolting P.R., de Groot E., Zwinderman A.H., Buirma R.J., Trip M.D., and Kastelein J.J. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: Treatment with simvastatin. Arch Intern Med 163 (2003) 1837-1841
32. Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, Isaac C, Garden GA, Maravilla KR, Hashimoto B, Hatsukami TS. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis doi:10.1016/j.atherosclerosis.2006.08.016 (in press).
33. Schartl M., Bocksch W., and Fateh-Moghadam S. Effects of lipid-lowering therapy on coronary artery remodeling. Coron Artery Dis 15 (2004) 45-51
34. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., and Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial. Lancet 357 (2001) 577-581
35. Takagi T., Yoshida K., Akasaka T., Hozumi T., Morioka S., and Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 79 (1997) 1673-1676
36. Tardif J.C. The future of intravascular ultrasound in the detection and management of coronary artery disease. Can J Cardiol 16 Suppl D (2000) 12D-15D
37. Tardif J.C., Gregoire J., Schwartz L., Title L., Laramee L., Reeves F., Lesperance J., Bourassa M.G., L'Allier P.L., Glass M., Lambert J., and Guertin M.C. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 107 (2003) 552-558
38. Tardif J.C., Gregoire J., L'Allier P.L., Ibrahim R., Lavoie M.A., LeMay M., Cohen E., Levesque S., Keller P.F., Heinonen T., and Guertin M.C. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. Am J Cardiol 98 (2006) 23-27
39. Taylor A.J., Kent S.M., Flaherty P.J., Coyle L.C., Markwood T.T., and Vernalis M.N. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 106 (2002) 2055-2060
40. Vesselinovitch D., Wissler R.W., Fisher-Dzoga K., Hughes R., and Dubien L. Regression of atherosclerosis in rabbits. I. Treatment with low-fat diet, hyperoxia and hypolipidemic agents. Atherosclerosis 19 (1974) 259-275
41. Von Birgelen C., Hartmann M., Mintz G.S., Bose D., Eggebrecht H., Gossl M., Neumann T., Baumgart D., Wieneke H., Schmermund A., Haude M., and Erbel R. Spectrum of remodeling behavior observed with serial long-term (≥12 mo) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol 93 (2004) 1107-1113
42. Wagner W.D., and Clarkson T.B. Effect on regression potential of atherosclerosis produced by intermittent or continuous hypercholesterolemia. Atherosclerosis 27 (1977) 369-381
43. Yuan C., Kerwin W.S., Yarnykh V.L., Cai J., Saam T., Chu B., Takaya N., Ferguson M.S., Underhill H., Xu D., Liu F., and Hatsukami T.S. MRI of atherosclerosis in clinical trials. NMR Biomed 19 (2006) 636-654